Publication | Closed Access

Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy

VaccinationPersonalized Peptide VaccinationVaccine DevelopmentHepatitis CHepatitis C VirusViral HepatitisVaccine TargetImmunologyHepatitisInterferon-based TherapyMedicine